Figure 3.
Figure 3. Normal surface expression of CD16 and 10N-nonyl acridine orange (NAO) staining in freshly isolated granulocytes from patients with BHTS. Fresh granulocytes from a control individual (left) and from a BTHS patient (right) were colabeled with annexin-V–FITC and anti-CD16–PE mAb (top; representative for 7 controls and patients tested) or stained with NAO (bottom; representative for 3 controls and patients tested) and analyzed by flow cytometry. In the top panels, CD16–/dull cells (circles) were identified as eosinophils by separate staining with anti-CD9 mAb (a specific eosinophil marker) and morphology of cytospin preparations (data not shown). In the bottom panels, values indicate mean fluorescence intensity (MFI) of NAO staining.

Normal surface expression of CD16 and 10N-nonyl acridine orange (NAO) staining in freshly isolated granulocytes from patients with BHTS. Fresh granulocytes from a control individual (left) and from a BTHS patient (right) were colabeled with annexin-V–FITC and anti-CD16–PE mAb (top; representative for 7 controls and patients tested) or stained with NAO (bottom; representative for 3 controls and patients tested) and analyzed by flow cytometry. In the top panels, CD16–/dull cells (circles) were identified as eosinophils by separate staining with anti-CD9 mAb (a specific eosinophil marker) and morphology of cytospin preparations (data not shown). In the bottom panels, values indicate mean fluorescence intensity (MFI) of NAO staining.

Close Modal

or Create an Account

Close Modal
Close Modal